Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4151–4200 of 35129
In accordance with the Emerson Electric Co. Statement of Corporate Governance Principles and Practices, Leticia Gonçalves Lourenco tendered her resignation from the Board of Directors (the “Board”) following a change in company and position relating to her principal occupation.
On March 7, 2025, the Board of Directors (the “Board”) of TuHURA Biosciences, Inc. (the “Company”) increased the size of the Board from five members to six members and appointed Dr. Craig Tendler to the Board, effective as of March 10, 2025, to serve as a director until the Company’s 2025 Annual Meeting of Stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal.
appointed Vickie Capps as a director.
On March 10, 2025, Pasha Sarraf was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc. (the “Company”), following the recommendation of the Corporate Governance and Nominating Committee of the Board.
On March 7, 2025, the board of directors (the “Board”) of Global Net Lease, Inc. (the “Company”) expanded its size from nine to ten directors and elected, effective immediately, Mr. Leon C. Richardson to serve as a member of the Board
appointed Monica Bertagnolli as a member of the Board, in each case effective as of March 6, 2025.
On March 11, 2025, Hope Bancorp, Inc. (the “Company”) director William J. Lewis notified the Company that he will not stand for re-election to the board of directors of the Company at the 2025 Annual Meeting of Stockholders and will retire following the annual meeting.
As of the Effective Time, Antonio J. Pietri, Robert M. Whelan, Jr., Patrick M. Antkowiak, Thomas F. Bogan, Karen M. Golz, David J. Henshall, Ram R. Krishnan and Arlen R. Shenkman each ceased to be directors of the Company
As of the Effective Time, Antonio J. Pietri, Robert M. Whelan, Jr., Patrick M. Antkowiak, Thomas F. Bogan, Karen M. Golz, David J. Henshall, Ram R. Krishnan and Arlen R. Shenkman each ceased to be directors of the Company
As of the Effective Time, Antonio J. Pietri, Robert M. Whelan, Jr., Patrick M. Antkowiak, Thomas F. Bogan, Karen M. Golz, David J. Henshall, Ram R. Krishnan and Arlen R. Shenkman each ceased to be directors of the Company
As of the Effective Time, Antonio J. Pietri, Robert M. Whelan, Jr., Patrick M. Antkowiak, Thomas F. Bogan, Karen M. Golz, David J. Henshall, Ram R. Krishnan and Arlen R. Shenkman each ceased to be directors of the Company
As of the Effective Time, Antonio J. Pietri, Robert M. Whelan, Jr., Patrick M. Antkowiak, Thomas F. Bogan, Karen M. Golz, David J. Henshall, Ram R. Krishnan and Arlen R. Shenkman each ceased to be directors of the Company
Upon the Effective Time, the Company became a wholly owned subsidiary of Parent. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Pursuant to the Merger Agreement, as of the Effective Time, the directors of Purchaser at the Effective Time became the directors of the Surviving Corporation. The directors of Purchaser at the Effective Time were Vincent M. Servello, James H. Thomasson and John A. Sperino.
As of the Effective Time, Antonio J. Pietri, Robert M. Whelan, Jr., Patrick M. Antkowiak, Thomas F. Bogan, Karen M. Golz, David J. Henshall, Ram R. Krishnan and Arlen R. Shenkman each ceased to be directors of the Company
Upon the Effective Time, the Company became a wholly owned subsidiary of Parent. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Pursuant to the Merger Agreement, as of the Effective Time, the directors of Purchaser at the Effective Time became the directors of the Surviving Corporation. The directors of Purchaser at the Effective Time were Vincent M. Servello, James H. Thomasson and John A. Sperino.
As of the Effective Time, Antonio J. Pietri, Robert M. Whelan, Jr., Patrick M. Antkowiak, Thomas F. Bogan, Karen M. Golz, David J. Henshall, Ram R. Krishnan and Arlen R. Shenkman each ceased to be directors of the Company
As of the Effective Time, Antonio J. Pietri, Robert M. Whelan, Jr., Patrick M. Antkowiak, Thomas F. Bogan, Karen M. Golz, David J. Henshall, Ram R. Krishnan and Arlen R. Shenkman each ceased to be directors of the Company
Upon the Effective Time, the Company became a wholly owned subsidiary of Parent. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Pursuant to the Merger Agreement, as of the Effective Time, the directors of Purchaser at the Effective Time became the directors of the Surviving Corporation. The directors of Purchaser at the Effective Time were Vincent M. Servello, James H. Thomasson and John A. Sperino.
On March 11, 2025, the Board of Directors (the “Board”) of Cherry Hill Mortgage Investment Corporation (the “Company”) increased the size of the Board from four directors to five directors and appointed Dale S. Hoffman as a director.
WNS (Holdings) Limited appointed Sylvie Ouziel to the Company’s Board of Directors effective April 1, 2025.
the Board expanded the size of the Board from eight to nine members and appointed Neal P. Goldman to the Board as a Class II director to fill the newly created vacancy.
appointed Mr. Sarrazin to serve as a Class III director.
On March 6, 2025, Ng Keok Chai resigned from his position as Independent Director and Head of the Audit Committee of Graphjet Technology (the “Company”).
On March 10, 2025, Tina Hunt informed the board of directors (the “Board”) of Veeva Systems Inc. (“Veeva”) of her intention to retire from her role as a director on the Board, effective immediately prior to the 2025 annual meeting of Veeva’s shareholders (the “2025 Annual Meeting”).
Mr. Robert Feitler from the Company’s Board of Directors (the “Board”) effective February 28, 2025
On March 7, 2025, the Board of Directors of the Company (the “Board”) appointed Peter Laurinaitis to serve as a Class III independent director effective immediately following the filing of the Company’s Annual Report on Form 10-K
On March 10, 2025, the Board of Directors (the “Board”) of NPK International Inc. (“the Company”) elected to increase the size of the Board from seven directors to eight directors effective March 10, 2025 and appointed Mr. Joseph A. Cutillo to fill the resulting vacancy.
On March 6, 2025, the Board appointed Ted Goldthorpe and Mark Ward as directors of the Board (collectively, the “New Directors”), with Mr. Goldthorpe serving as Chairman.
On March 10, 2025, the Board of Directors (the “Board”) of Smurfit Westrock plc (the “Company”) appointed Carole L. Brown to the Board as an independent director, effective March 11, 2025.
As previously disclosed, Dmitri L. Stockton will be stepping down from the Board, effective as of the conclusion of the Company’s 2025 Annual General Meeting of Shareholders
the Board of Directors of Vitesse (the “Board”) approved an increase in the size of the Board from seven to nine directors and appointed M. Bruce Chernoff and Gary D. Reaves.
the Board of Directors of Vitesse (the “Board”) approved an increase in the size of the Board from seven to nine directors and appointed M. Bruce Chernoff and Gary D. Reaves.
On March 10, 2025, the Board appointed John W. Shiver, Ph.D. to the Company’s Board, effective on such date, to fill the vacancy created by Dr. Young’s resignation and to serve as a Class III director for a term expiring at the Company’s 2025 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal.
On March 9, 2025, Fred Craves, Ph.D. provided notice of his resignation from the Board of Directors (the “Board”) of Madrigal Pharmaceuticals, Inc. (the “Company”), effective as of July 1, 2025.
On March 10, 2025, following the recommendation of its Nominating and Governance Committee, the Board expanded the size of the Board from nine to ten members and elected Jackie Fouse, Ph.D. to fill the newly created vacancy.
On March 11, 2025, Las Vegas Sands Corp.’s (the “Company’s”) Board of Directors (the “Board”) elected Muktesh “Micky” Pant as a new member of the Board, effective immediately.
On March 7, 2025, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Charles E. Beard, Jr. as a member of the Board.
On March 6, 2025, the Board of Directors (the “Board”) of ICF International, Inc. (the “Company”) increased the size of the Company’s Board from seven (7) to eight (8) members and announced the appointment of Ms. Caroline Angoorly to the Board.
The Board appointed Mr. Neugeboren to serve as a member of the Audit Committee and as Chair of the Compensation Committee.
On February 10, 2025, Natasha Giordano informed the Board of Directors (the “ Board ”) of Matinas BioPharma Holdings, Inc. (the “ Company ”) that she was resigning from the Board effective February 11, 2025, due to her other professional obligations.
On February 10, 2025, Matthew Wikler informed the Board that he was resigning from the Board effective February 11, 2025, due to his other professional obligations.
Effective as of March 11, 2025, the Board, on the recommendation of the Governance Committee, appointed Keith Murphy and Edward Neugeboren directors of the Company to replace Ms. Giordano and Mr. Wikler, respectively.
On March 6, 2025 and March 7, 2025, Ryan Wright and David Jolley were elected as directors of Domo, Inc. (the "Company"), effective March 6, 2025 and March 7, 2025, respectively
On March 6, 2025 and March 7, 2025, Ryan Wright and David Jolley were elected as directors of Domo, Inc. (the "Company"), effective March 6, 2025 and March 7, 2025, respectively
On March 5, 2025, Dr. Stefan Piëch, a member of the Board of Directors (the “Board”) of Kartoon Studios, Inc. (the “Company”), notified the Company of his decision to resign, effective as such date, from his position as a member of the Board.
On March 11, 2025, Sandra J. DiCocco was appointed as Chairman of the Board of Directors of the Company, and Vincent Monteparte, Ross David Gourdie and Amy Scannell were appointed members of the Board of Directors.
On March 11, 2025, Sandra J. DiCocco was appointed as Chairman of the Board of Directors of the Company, and Vincent Monteparte, Ross David Gourdie and Amy Scannell were appointed members of the Board of Directors.
Further, on March 7, 2025, Anthony Merchant and Alejandro Araujo were appointed as members of the Board of Directors of the Company.
Further, on March 7, 2025, Anthony Merchant and Alejandro Araujo were appointed as members of the Board of Directors of the Company.
appointed as a member of the Board of Directors
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.